Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT04393298
Title	A Study to Assess the Safety, Pharmacokinetics and Antitumor Activity of UCB6114 Administered Intravenously to Participants With Advanced Solid Tumors
Recruitment	Active, not recruiting
Gender	both
Phase	Phase Ib/II
Variant Requirements	No
Sponsors	UCB Biopharma SRL
Indications	gastroesophageal junction adenocarcinoma head and neck squamous cell carcinoma esophageal carcinoma breast carcinoma lung squamous cell carcinoma colorectal adenocarcinoma prostate adenocarcinoma pancreatic adenocarcinoma gastric adenocarcinoma lung adenocarcinoma bladder urothelial carcinoma
Therapies	UCB6114 Trifluridine-tipiracil hydrochloride + UCB6114 Fluorouracil + Leucovorin + Oxaliplatin + UCB6114
Age Groups:	senior \| adult
Covered Countries	USA \| GBR